InvestorsHub Logo

djjazzyjeff

05/16/24 10:30 AM

#232364 RE: $5.95akadawson-m #232361

You moron those "partnerships" are where this disaster gives lerloonymab to university researchers in exchange for squat. Yeah that long lasting lermoobybooby partnership has been going great! How many years has it been? LAUGHING!!!!

$5.95akadawson-m

05/16/24 12:45 PM

#232370 RE: $5.95akadawson-m #232361

Let's review a part of today's shareholder letter - for those who have a hard time understanding it, I will help with the explanation:

Over the next six months, we expect to commence at least one, and potentially two clinical trials. The prospective clinical trials, in order of priority, are: (i) a Phase II study of leronlimab in patients with relapsed/refractory microsatellite stable colorectal cancer; and (ii) a Phase II study exploring leronlimab’s effects on inflammation. The Company’s priority will be the oncology trial which, if successful, will put us on track towards a commercial approval of leronlimab in that indication.

This sentence: "The Company’s priority will be the oncology trial which, if successful, will put us on track towards a commercial approval of leronlimab in that indication."

"Put us on track towards a commercial approval...." This "indication" is an unmet need, today. An unmet need means that no one has been able to successfully treat colorectal cancer! And, it's a Phase II. The gravy train starts after the completion of the Phase II. All aboard, Grip It!